ClearPoint Neuro, Inc. (CLPT)
Company Info
| ISIN | US18507C1036 |
|---|---|
| CUSIP | 18507C103 |
| Sector | Healthcare |
| Industry | Medical Devices |
Highlights
| Market Cap | $160.68M |
|---|---|
| EPS | -$0.83 |
| Revenue (TTM) | $26.16M |
| Gross Profit (TTM) | $13.53M |
| EBITDA (TTM) | -$20.23M |
| Year Range | $4.05 - $9.05 |
| Target Price | $10.00 |
| Short % | 5.10% |
| Short Ratio | 12.23 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in ClearPoint Neuro, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
ClearPoint Neuro, Inc. had a return of -8.69% year-to-date (YTD) and -26.01% in the last 12 months. Over the past 10 years, ClearPoint Neuro, Inc. had an annualized return of -15.96%, while the S&P 500 had an annualized return of 10.99%, indicating that ClearPoint Neuro, Inc. did not perform as well as the benchmark.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | -8.69% | 11.18% |
| 1 month | 12.12% | 5.60% |
| 6 months | 20.16% | 17.48% |
| 1 year | -26.01% | 26.33% |
| 5 years (annualized) | 13.80% | 13.16% |
| 10 years (annualized) | -15.96% | 10.99% |
Monthly Returns
The table below presents the monthly returns of CLPT, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 2.50% | -8.19% | 6.42% | -20.15% | -8.69% | ||||||||
| 2023 | 12.28% | -10.83% | -0.47% | 24.64% | -26.81% | -5.97% | -5.11% | -15.43% | -13.77% | 9.78% | 4.73% | 17.88% | -19.83% |
| 2022 | -21.30% | -0.91% | 18.97% | -17.68% | 27.89% | 19.07% | 8.58% | -9.17% | -19.50% | -3.38% | -5.79% | -10.18% | -24.51% |
| 2021 | 48.71% | -0.89% | -9.74% | -1.47% | -11.57% | 3.64% | 16.45% | -15.11% | -5.94% | -5.75% | -17.93% | -18.28% | -29.39% |
| 2020 | 8.33% | -5.38% | -27.24% | 5.03% | 8.24% | -12.53% | 25.00% | -1.35% | 24.37% | 28.21% | 52.86% | 48.50% | 231.04% |
| 2019 | 65.61% | 14.23% | 7.74% | -11.25% | 14.44% | -1.54% | 25.00% | -2.00% | 29.08% | -22.33% | 2.80% | 18.81% | 205.73% |
| 2018 | 9.09% | 8.33% | 1.54% | -10.61% | -28.81% | 2.38% | -6.98% | -20.00% | 25.00% | -3.00% | -2.06% | -17.37% | -42.91% |
| 2017 | -21.18% | 2.61% | 81.82% | 20.00% | -50.00% | 23.33% | -45.95% | -5.00% | 26.32% | 10.42% | 7.55% | -3.51% | -19.12% |
| 2016 | 2.63% | -23.08% | 6.67% | 28.13% | -41.46% | -4.17% | -13.15% | -24.28% | -0.17% | -19.70% | -55.67% | 58.14% | -77.63% |
| 2015 | -9.64% | 9.33% | 26.83% | 3.85% | -5.56% | 6.86% | -13.76% | -20.21% | -20.00% | -6.67% | -17.86% | -17.39% | -54.22% |
| 2014 | -6.21% | -8.09% | -4.00% | 3.33% | -31.45% | 45.88% | -12.10% | -8.26% | 20.00% | -11.67% | -13.21% | -9.78% | -42.76% |
| 2013 | 5.00% | -12.50% | -17.69% | -6.61% | 3.54% | -5.98% | 5.45% | 12.07% | 14.62% | 0.67% | 0.67% | -3.97% | -9.38% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of CLPT is 23, indicating that it is in the bottom 23% of stocks on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.
CLPT (ClearPoint Neuro, Inc.)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for ClearPoint Neuro, Inc. (CLPT) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the ClearPoint Neuro, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the ClearPoint Neuro, Inc. was 99.22%, occurring on Sep 21, 2018. The portfolio has not yet recovered.
The current ClearPoint Neuro, Inc. drawdown is 96.52%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.22% | Jul 6, 2012 | 1564 | Sep 21, 2018 | — | — | — |
| -45.65% | Jun 11, 2012 | 7 | Jun 19, 2012 | 6 | Jun 27, 2012 | 13 |
| -8.33% | Jun 4, 2012 | 1 | Jun 4, 2012 | 2 | Jun 6, 2012 | 3 |
| -4.76% | May 31, 2012 | 1 | May 31, 2012 | 1 | Jun 1, 2012 | 2 |
| -3.7% | Jun 7, 2012 | 1 | Jun 7, 2012 | 1 | Jun 8, 2012 | 2 |
Volatility
Volatility Chart
The current ClearPoint Neuro, Inc. volatility is 12.32%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | 0.00 |
Cost Of Revenue | 0.00 |
Gross Profit | 0.00 |
| Operating Expenses | |
Selling, General & Admin Expenses | 0.00 |
R&D Expenses | 0.00 |
Total Operating Expenses | 0.00 |
| Income | |
Income Before Tax | 0.00 |
Operating Income | 0.00 |
EBIT | 0.00 |
Earnings From Continuing Operations | 0.00 |
Net Income | 0.00 |
Income Tax Expense | 0.00 |
Interest Expense | 0.00 |
Other Non-Operating Income (Expenses) | 0.00 |
Extraordinary Items | 0.00 |
Discontinued Operations | 0.00 |
Effect Of Accounting Charges | 0.00 |
Non Recurring | 0.00 |
Minority Interest | 0.00 |
Other Items | 0.00 |